Interest of Antiplatelet Drug Testing after an Acute Ischemic Stroke

Publisher： Karger

E-ISSN： 1421-9913|74|3-4|135-139

ISSN： 0014-3022

Source： European Neurology, Vol.74, Iss.3-4, 2015-09, pp. : 135-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Progress in Drug Treatment for Acute Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 11, Iss. 1, 2010-04 ,pp. : 71-79

Karger

Access to resources Recommend Favorite

Antiplatelet Drugs for Ischemic Stroke Prevention

By  

Cerebrovascular Diseases, Vol. 27, Iss. 1, 2009-04 ,pp. : 120-125

Karger

Access to resources Recommend Favorite

Long‐Term Antiplatelet Mono‐ and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta‐Analysis

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 8, 2015-08 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Edaravone (Radical Scavenger) versus Sodium Ozagrel (Antiplatelet Agent) in Acute Noncardioembolic Ischemic Stroke (EDO Trial)

By  

Cerebrovascular Diseases, Vol. 27, Iss. 5, 2009-03 ,pp. : 485-492

Karger

Access to resources Recommend Favorite

Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy: A Systematic Review and Meta‐analysis of 19 Studies

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 5, 2016-05 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite